Belsky Marc 4
4 · Kezar Life Sciences, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-07+295,000→ 295,000 totalExercise: $0.93Exp: 2034-01-06→ Common Stock (295,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 7, 2024, subject to the Reporting Person continuing to provide service through each such date.